Author: Daniel Zaharia

About the publisher

Daniel Zaharia is the publisher of This Hour, an independent English-language news publication covering AI, technology, business, finance, science, health and world affairs.

He is responsible for the publication's editorial framework, source standards and correction process. This Hour uses AI-assisted tools for discovery, source comparison and drafting; articles include source context and are updated when material facts change.

Read the Editorial Policy

BIOHYBRID Trial Sets Hybrid PCI Strategy Against Drug-eluting Stents in Diffuse Coronary Disease

The registered BIOHYBRID study proposes a comparison between a scaffold-and-drug-coated-balloon PCI approach and a strategy using multiple newer-generation drug-eluting stents for long or diffuse coronary lesions. Its key 12-month measure is change in vessel-level FFRangio.

Read More

Follow Us

Advertisements